Updated Jul 16, 2026
Carter Eric G has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Carter Eric G is listed as a director of AEON Biopharma, Inc. in SEC filings dated around 2026-06-22. Public records accompanying these filings indicate a governance role with the company, but there is limited publicly available biographical information about his career history, education, or prior positions in relation to this filing context.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | AEON | AEON Biopharma, Inc. | A — Grant or award | 222.7K | $0.00 |
Carter Eric G is listed as a director of AEON Biopharma, Inc. in SEC filings dated around 2026-06-22. Public records accompanying these filings indicate a governance role with the company, but there is limited publicly available biographical information about his career history, education, or prior positions in relation to this filing context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carter Eric G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.